Hydroxychloroquine: balancing the needs of LMICs during the COVID-19 pandemic.
作者信息
Banerjee Soumya
机构信息
Department of Psychiatry, University of Cambridge, Cambridge, UK.
出版信息
Lancet Rheumatol. 2020 Jul;2(7):e385-e386. doi: 10.1016/S2665-9913(20)30162-4. Epub 2020 May 27.
Abstract
摘要
相似文献
1
Hydroxychloroquine: balancing the needs of LMICs during the COVID-19 pandemic.羟氯喹：在新冠疫情期间平衡中低收入国家的需求
Lancet Rheumatol. 2020 Jul;2(7):e385-e386. doi: 10.1016/S2665-9913(20)30162-4. Epub 2020 May 27.
2
Battling against the great disruption to surgical care in a pandemic: experiences of 11 South and Southeast Asian countries.应对大流行期间外科护理的巨大中断：11 个南亚和东南亚国家的经验。
BMJ Open. 2023 Apr 10;13(4):e060770. doi: 10.1136/bmjopen-2022-060770.
3
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 的疗效。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547. doi: 10.26355/eurrev_202004_21038.
4
Research priorities to reduce the impact of COVID-19 in low- and middle-income countries.降低新冠疫情在低收入和中等收入国家影响的研究重点。
J Glob Health. 2022 Apr 15;12:09003. doi: 10.7189/jogh.12.09003. eCollection 2022.
5
Hydroxychloroquine for COVID-19: Balancing contrasting claims.用于治疗新冠肺炎的羟氯喹：权衡相互矛盾的说法。
Eur J Intern Med. 2020 Dec;82:25-26. doi: 10.1016/j.ejim.2020.11.018. Epub 2020 Nov 23.
6
Association Between X/Twitter and Prescribing Behavior During the COVID-19 Pandemic: Retrospective Ecological Study.X/Twitter 与新冠大流行期间的处方行为之间的关联：回顾性生态研究。
JMIR Infodemiology. 2024 Nov 18;4:e56675. doi: 10.2196/56675.
7
Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine.在大流行期间是否可以进行临床试验？羟氯喹试验的例子。
Epidemiol Prev. 2021 Jan-Apr;45(1-2):28-36. doi: 10.19191/EP21.1-2.P028.036.
8
Medication safety in a pandemic: A multicentre point prevalence study of QTc monitoring of hydroxychloroquine for COVID-19.大流行期间的药物安全：COVID-19 羟氯喹 QTc 监测的多中心时点患病率研究。
J Clin Pharm Ther. 2021 Oct;46(5):1308-1311. doi: 10.1111/jcpt.13429. Epub 2021 May 6.
9
Correlation of the rise and fall in COVID-19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis.巴西南里奥格兰德州圣卡塔琳娜州 COVID-19 病例的增减与社会隔离指数以及羟氯喹和氯喹早期门诊治疗的相关性：回顾性分析。
Travel Med Infect Dis. 2021 May-Jun;41:102005. doi: 10.1016/j.tmaid.2021.102005. Epub 2021 Mar 2.
10
Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19.与新冠病毒疾病（Covid-19）羟氯喹治疗处方相关的伦理问题。
Ethics Med Public Health. 2020 Jul-Sep;14:100547. doi: 10.1016/j.jemep.2020.100547. Epub 2020 Jun 17.
引用本文的文献
1
What if the worst consequences of COVID-19 concerned non-COVID patients?如果 COVID-19 最严重的后果涉及非 COVID 患者，该怎么办？
J Infect Public Health. 2020 Sep;13(9):1237-1239. doi: 10.1016/j.jiph.2020.06.014. Epub 2020 Jun 15.
本文引用的文献
1
Unity amidst uncertainty: COVID-19 pandemic fosters collaboration in rheumatology community.不确定性中的团结：新冠疫情促进了风湿病学界的合作。
Lancet Rheumatol. 2020 May;2(5):e245. doi: 10.1016/S2665-9913(20)30082-5. Epub 2020 Apr 16.
2
Use of antiviral drugs to reduce COVID-19 transmission.使用抗病毒药物减少新冠病毒传播。
Lancet Glob Health. 2020 May;8(5):e639-e640. doi: 10.1016/S2214-109X(20)30114-5. Epub 2020 Mar 19.
3
The global burden of SLE: prevalence, health disparities and socioeconomic impact.系统性红斑狼疮的全球负担：患病率、健康差异和社会经济影响。
Nat Rev Rheumatol. 2016 Oct;12(10):605-20. doi: 10.1038/nrrheum.2016.137. Epub 2016 Aug 25.
4
Hydroxychloroquine in systemic lupus erythematosus.羟氯喹在系统性红斑狼疮中的应用
Lancet. 2007 Apr 14;369(9569):1257-1258. doi: 10.1016/S0140-6736(07)60591-1.
Zotero 插件